OTTAWA, March 13, 2015 /CNW/ - Annidis Corporation (TSX Venture: RHA) ("Annidis" or the "Company") a leader in Multi-Spectral Imaging technology used to enhance ocular health, announced today that its CEO, Gerald Slemko, is scheduled to appear on the Business News Network (BNN) with Frances Horodelski on Friday, March 13 at 11:10 am ET. Mr. Slemko will discuss the Company's revolutionary technology for early detection of outer retinal and choroidal disorders, and recent announcement on its involvement with NASA's National Space Biomedical Research Institute (NSBRI) to develop unique technologies that address visual problems experienced by astronauts in space as well as on Earth.
About Annidis Corporation
Annidis (TSX-V: RHA) has developed and is marketing a new imaging platform technology based on Multi-Spectral Imaging (MSI). This new technology is opening a new frontier in disease identification and its management. The Annidis MSI technology allows eye-care professionals to view non-invasively the deepest areas of the eye aiding eye care professionals in the early identification and treatment of debilitating eye diseases. The Company's existing RHA 2020-U Gold, used by eye care professionals as a broad based tool for detecting early-onset of eye related diseases such as Dry AMD, has a potential market of over 20,000 clinics in North America. The RHA Platinum MD will further strengthen the value proposition allowing doctors to visualize choroidal and retinal vasculature non-invasively. The RHA Platinum MD has global market potential of more than 100,000 Ophthalmologists.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release
SOURCE Annidis Corporation
For further information: Gerald Slemko, Chief Executive Officer, Annidis Corporation, (519) 858-1582 ext. 239, email@example.com; Babak Pedram, Investor Relations, Virtus Advisory Group Inc., 416-995-8651, firstname.lastname@example.org